2018;34(8):e3061
For researchers exploring anti-inflammatory peptide approaches , penta deca peptide arginate offers a mechanism that modulates rather than suppresses inflammatory processes
DESTINY-Lung01, a phase II trial evaluating the efficacy of T-DXd in pre-treated NSCLC harboring HER2 molecular alterations includes two cohorts of patients: The HER2 -mutant cohort included 91 patients, showing an ORR of 55%, a median DoR of 9.3 months (95% CI, 5.7 to 14.7) and medians PFS and OS of 8.2 (95% CI, 6.0 to 11.9) and 17.8 months (95% CI, 13.8 to 22.1), respectively [4,33,34]
When glutathione does its job and becomes oxidized, vitamin C can step in to provide the electrons needed to turn it back into its active, "reduced" state
Why just get more sleep rarely works Insomnia is not always a lack of effort